Loading...
NPI 1699795500 · Lakewood, CO · Pharmacy
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Walgreen Co is a pharmacy provider located in Lakewood, Colorado. This profile covers 23 Medicare and 10 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Walgreen Co |
| Address | 12880 W Alameda Pkwy |
| City | Lakewood |
| State | CO |
| ZIP | 80228 |
| Taxonomy | Pharmacy |
| NPI Enumerated | July 20, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $108.9M |
| Medicaid | $19.9K |
WALGREEN CO’s billing mix is dominated by vaccination and COVID-related services, consistent with a retail pharmacy operating mass immunization and testing workflows. Top Medicare activity includes SARS–CoV–2 vaccine codes 91320 (169.5K claims, $21M revenue) and 91322 (133.6K claims, $17.8M revenue), the COVID test K1034 (1.5M claims, $18.2M revenue), plus high-volume administration codes such as 90480 (303.2K claims, $10.9M revenue) and G0008 (302.8K claims, $9.4M revenue).
Medicare revenue is highly concentrated: the precomputed top 3 Medicare codes together account for 52.1% of the provider’s total Medicare revenue. Those top three contributors are 91320 ($21M, 19.2% of Medicare revenue), K1034 ($18.2M, 16.6%), and 91322 ($17.8M, 16.3%), indicating a narrow set of services drives the majority of Medicare dollars.
On national competitive standing for Medicare vaccine and test codes, WALGREEN CO is a market leader and extreme outlier on multiple measures. Several codes rank at the very top nationally — 91320 ranks #1 of 27083 providers (100th percentile; extreme outlier), 91322 ranks #1 of 29357 providers (100th percentile; extreme outlier), 90480 ranks #1 of 46950 providers (100th percentile; extreme outlier), and G0008 ranks #1 of 119096 providers (100th percentile; extreme outlier) — signalling volumes far above typical national peers for immunization/testing services.
By scale of payers this entity is effectively Medicare-dominant: lifetime Medicare revenue is $108.9M versus just $19.9K in lifetime Medicaid revenue. The gap in magnitude shows the provider’s commercial and public-health activity is concentrated in Medicare billing rather than Medicaid.
Medicaid billing is modest and concentrated in a small set of low-dollar codes: the precomputed top 3 Medicaid codes account for 58.6% of Medicaid revenue, led by E1399 (131 claims, $5.2K revenue, 26.2% of Medicaid revenue), 0064A (196 claims, $3.7K revenue, 18.7%), and A4253 (98 claims, $2.7K revenue, 13.7%). In-state ranks for these Medicaid codes are mixed and generally unremarkable (E1399 #109 of 249, 56th percentile; 0064A #23 of 220, 90th percentile; A4253 #240 of 354, 32nd percentile), underscoring a modest Medicaid footprint.
The provider’s claim volumes demonstrate exceptional throughput for immunizations and COVID testing, supporting an operational model focused on high-volume point-of-care services. Examples include 1.5M claims for K1034, 303.2K claims for 90480, 302.8K claims for G0008, 169.5K claims for 91320 and 178.4K claims for 90662; many of these entries are labeled as "extreme outlier" or rank at the top of national distributions, which aligns with a mass-vaccination/testing capacity.
There are isolated Medicaid data quirks that merit attention when reconciling payer records: for example, 91306 appears with 196 claims and $0 revenue while ranking #7 of 99 in-state (94th percentile; notably above typical state volume). This pattern — high claim counts with $0 recorded Medicaid payments on certain vaccine product codes — suggests differences in how manufacturer-supplied or program-distributed vaccines are reported to Medicaid rather than a meaningful revenue stream.
WALGREEN CO has a long-enumerated presence on file, with NPI enumeration dated 2006-07-20 (~20 years ago), indicating established operational tenure that likely supported scaling to the high vaccination and testing volumes seen in the Medicare data.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
23 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 169,540 | $120 | $21M |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 1,512,850 | $10 | $18.2M |
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 133,650 | $130 | $17.8M |
| 90662 | This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection… | 178,350 | $70 | $11.9M |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 303,190 | $40 | $10.9M |
| G0008 | Administration of influenza virus vaccine | 302,790 | $30 | $9.4M |
| 90677 | This code represents a vaccine product administered intramuscularly to protect against pneumococcal disease, a bacterial infection. This is a 20–valent vaccine, protecting against 20 strains of the… | 30,900 | $270 | $8.2M |
| 90694 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is an inactivated, adjuvanted, preservative–free vaccine given as a 0.5 mL… | 105,920 | $70 | $7.4M |
| 0124A | N/A | 38,160 | $40 | $1.6M |
| 0134A | N/A | 30,710 | $40 | $1.3M |
Showing 1–10 of 23
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 23 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
10 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| E1399 | Durable medical equipment, miscellaneous | 130 | $40 | $5.2K |
| 0064A | N/A | 200 | $20 | $3.7K |
| A4253 | Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips | 100 | $30 | $2.7K |
| 0012A | N/A | 90 | $30 | $2.7K |
| 0011A | N/A | 110 | $20 | $2.4K |
| 90471 | In this procedure, the provider administers a live attenuated vaccine using a percutaneous, intradermal, subcutaneous, or intramuscular route. | 190 | $10 | $1.9K |
| 90686 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is preservative free, uses split virus technology, and is given as a 0.5 mL… | 100 | $10 | $1K |
| 90674 | This code represents a flu vaccine product that protects against four strains of influenza. It is derived from cell cultures, contains no preservatives or antibiotics, and is administered as a 0.5 mL… | 30 | $10 | $200 |
| 91301 | N/A | 430 | $0 | $0 |
| 91306 | N/A | 200 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Colorado providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Colorado median
10 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| E1399 | Durable medical equipment, miscellaneous | 109 | 250 | 100 | $340 | $116K |
| A4253 | Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips | 240 | 350 | 280 | $30 | $20.7K |
| 90471 | In this procedure, the provider administers a live attenuated vaccine using a percutaneous, intradermal, subcutaneous, or intramuscular route. | 452 | 1,210 | 110 | $10 | $13.2K |
| 0012A | N/A | 118 | 340 | 60 | $30 | $6K |
| 0011A | N/A | 109 | 360 | 60 | $30 | $5K |
| 90686 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is preservative free, uses split virus technology, and is given as a 0.5 mL… | 389 | 860 | 80 | $10 | $3.2K |
| 0064A | N/A | 23 | 220 | 40 | $30 | $3.2K |
| 90674 | This code represents a flu vaccine product that protects against four strains of influenza. It is derived from cell cultures, contains no preservatives or antibiotics, and is administered as a 0.5 mL… | 122 | 200 | 40 | $20 | $1.8K |
| 91301 | N/A | 29 | 170 | 120 | $1 | $1 |
| 91306 | N/A | 7 | 100 | 50 | $0 | $0 |
Other providers in the same ZIP code as Walgreen Co, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.